Dutch IT company brings GDP-compliant, real-time cold chain monitoring to life sciences

Saying that its updated software platform, DyzleLiveWare, has been updated to encompass Europe’s new Good Distribution Practices (GDP) guidelines, Dyzle BV is now bringing the technology to the US market, and will be exhibiting its capabilities at this fall’s IQPC Cold Chain meeting. The Almere, Netherlands, company has a handful of clients at leading pharma-distribution and healthcare-provider organizations in Europe, and received a third round of private investment last year. Clients include Alliance Healthcare and the Dutch National Institute for Public Health and the Environment.

Dyzle’s solution comprises RFID-enabled tags to measure temperature, relative humidity and other parameters, a base station datalogger called a Y Gate that collects data from these tags, and links to the Internet. Another product offering, DyzleSmartWare, aggregates and performs analytics on these data, and generates reports and alarms. The company is engaged in an ongoing effort to provide interfaces to third parties, presumably logistics services providers, warehouses and other participants in life sciences distribution.

“We’ve invested over Euro $10 million in developing what is a really complex and fully scalable product at the back-end, but made extremely simple to use as far as the customer is concerned. With one view, we provide complete end-to-end visibility of the cold chain on any internet enabled device, enabling automatic registration that is needed to meet the new GDP guidelines,” said Bert Zandhuis, CEO of Dyzle, in a statement.